Related Experiment Video
Updated: Jul 28, 2025

10:02
Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
2.0K
Evidence versus expectancy: the development of psilocybin therapy
1Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
Bjpsych Bulletin
|May 29, 2023
Summary
Psilocybin therapy shows promise for treatment-resistant depression, but challenges remain in distinguishing drug effects from expectancy effects. Further research is needed to measure these factors in clinical trials.
Area of Science:
- Psychiatry
- Neuroscience
- Pharmacology
Background:
- Modern research on psilocybin therapy has advanced over 25 years.
- Psilocybin therapy integrates dosing with psychoeducation, support, and integration.
- Early clinical trials suggest promise, especially for treatment-resistant depression.
Purpose of the Study:
- To summarize the clinical development of psilocybin therapy.
- To discuss the challenges and opportunities in psilocybin research.
- To highlight the need to disambiguate drug and expectancy effects.
Main Methods:
- Review of ongoing clinical development of psilocybin therapy.
- Discussion of challenges including masking and expectancy effects.
- Emphasis on the need for routine measurement of masking and expectancy.
Main Results:
- Early phase clinical trial evidence for psilocybin therapy is promising.
- Treatment-resistant depression is a key area of focus.
- Masking and expectancy effects may influence therapeutic outcomes.
Conclusions:
- Disentangling drug effects from expectancy effects is crucial for psilocybin therapy development.
- Measuring masking and expectancy in trials is an opportunity for psychiatric research.
- Further research is needed to understand the mechanisms of change in psilocybin therapy.
More Related Videos
Related Concept Videos
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Psychosis: Goals of Pharmacotherapy
172
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
172
Hallucinogens and Psychedelics
216
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
216
CNS Stimulants: Psychedelic Agents
196
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
196
Psychodynamic Therapy
99
Psychodynamic therapies emphasize the exploration of unconscious processes and early childhood experiences as fundamental contributors to psychological difficulties. These therapies, deeply rooted in Freud's psychoanalytic theory, aim to uncover and resolve unconscious conflicts, granting individuals insights that promote emotional and behavioral healing. Contemporary psychodynamic approaches have evolved, integrating a broader range of influences and methodologies while still valuing the...
99
Electroconvulsive Therapy
83
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
83

